Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 35Recurrence 9Neoplasms 3Sarcoma, Kaposi 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multi-centric Castleman's Disease 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Chromosome 17 deletion 1Alzheimer Disease 1Acquired Immunodeficiency Syndrome 1

Interventions

pomalidomide 1daratumumab 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Chromosome 17 deletion × pomalidomide × Clear all
NCT04124497 2025-08-08

DPd

Fondazione EMN Italy Onlus

Phase 2 Active not recruiting
45 enrolled
Plasma cell

Chromosome 17 deletion, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡